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By H. WOMBACHER and F. KÖRBER
Zentralinstitut für Biochemie und Biophysik der Freien Universität Berlin
(Eingegangen am 21. Februar 1972)
A cyclic adenosine 3': 5'-monophosphate (Ado-3':5'-P) assay is proposed basing on the principle of competitive protein-binding.
Free and bound Ado-3':5'-P is separatedjby coated (Dextran T 70, bovine serum albumine) charcoal. The Ado-3':5'-P binding protein
is obtained from bull adrenals. The detection limit is 0.25 pmol in the incubation tube. The affinity constant of the protein-Ado-3': 5'-P
complex is 2.8 · 108l/mol. The free enthalpy is approximate lOkcal/mol. The high specificity is tested with other similar nucleotides.
There is a great difference between the N6-mono- and N6-2'O-dibutyryl derivatives of Ado-3':5'-P with respect to their affinities for the
binding protein, or protein kinase.
The criteria of reliability are given by precision, detection limit, specificity and accuracy data.
The method is suitable for serial determinations. One person is able to measure 100 samples (including the standard curve) per day.
For linearisation of the dose response curve a new method is described. The proposed plot has the advantages of simplicity and ease of
curve calculation. In addition, the plot yields the affinity constant and binding capacity of the binding protein. Moreover, this method
allows the estimation of the affinity constant of any competitor of a labeled ligand. This method for linearisation is discussed regarding
its limitations and advantages.
Es wird eine Bestimmungsmethode für cyclisches Adenosin-3': S'-monophosphat (Ado-3': 5'-P) vorgeschlagen, die auf einer kompetitiven
Verdrängungsreaktion von 3H- und nichtmarkiertem Ado-3':5'-P an einem spezifisch Ado-3':5'-P bindenden Protein beruht, das aus
Nebennieren von Stieren erhalten wird. Die Trennung von freiem und gebundenem Ado-3': 5'-P erfolgt durch mit Dextran T 70 und
Rinderserumalbumin vorbehandelter Aktivkohle. Die Nachweisgrenze für Ado-3': 5'-P liegt bei 0,25 pMol (p ̂  0,05) im Bestimmungs-
ansatz. Die Affinitätskonstante beträgt 2,8 · l O8 l/Mol. Die freie Enthalpie für die Reaktion der Anlagerung von Ado-3':5'-P an das
bindende Protein beläuft sich auf etwa 10 kcal/Mol. Die Spezifität der Methode ist hoch; ähnlich gebaute Nucleotide sind weitgehend
ohne Einfluß auf die Reaktion. Für die beiden Ado-3': 5'-P-Derivate N6-Mono- und N6-2'O-Dibutyryl-Ado-3/:5/-P besteht ein großer
Unterschied in der Affinität zum bindenden Protein bzw. der Proteinkinase.
Die Zuverlässigkeit der Methode wird mit Daten für die Präzision, die Nachweisgrenze, die Spezifität und die Richtigkeit belegt.
Die Methode ist für Serienbestimmungen geeignet; eine Assistentin kann etwa 100 Proben (einschließlich Standard-Kurve) am Tag messen.
Zur Linearisierung der Dosis-Wirkungskurve wird eine neue Methode beschrieben, deren Vorteile und Grenzen diskutiert werden.
Die vorgeschlagene graphische Darstellung erlaubt eine einfache Kurvenberechnung sowie die Ermittlung der Affinitätskonstante und
der Bindungskapazität des Bindungsproteins. Darüberhinaus kann unter Verwendung nur eines markierten Liganden die Affinitäts-
konstante für jede kompetitiv wirksame Verbindung bestimmt werden.
The original and most commonly used analytical Many of the methods mentioned above are less than
method for Ado-3': 5'-P detection is based on phos- ideal from the standpoint of standardisation, sensitivity
phorylase kinase (EC 2.7.1.38) activation (1, 2). An- and specificity, and all are laborious,
other method depends on the ability of specific protein Recently a method for determination of Ado-3' :5'-P
kinases (EC 2.7.1.) to phosphorylate histones or casein has been proposed, based on a specific Ado-3':5'-P
with ATP-[y-32P] (3, 4). The following methods have binding to a protein. Both a radioimmuno-assay
been developed for detecting Ado-3' :5'-P: The nu- (STEINER and coworkers (13)) and a competitive pro-
cleotide is enzymatically converted to ADP-[/J-32P] (5), tein-binding assay (OILMAN (14), WALTON arid GARREN
or to ATP, and the latter is measured either by a (15)) were developed. In the latter case Ado-3':5'-P
radioactive phosphate exchange reaction with coupled is specifically bound on a protein kinase from muscle or
enzymes (6) or luciferase method (7). Alternatively adrenal gland (16—20).
the enzymatic cycling developed by BRECKENRIDGE (8), The assay proposed by us makes use of the principle
or the resulting ATP, is assayed by 14CO2 evolved from of competitive protein binding.
glucose-[l-14C] by sequential enzymatic reactions (9). The binding protein is extracted from bull adrenal-
Chromatographic methods are proposed by BRADHAM gland homogenates by centrifugation. It can be used
and WOOLEY (10) and KRISHNA and coworkers (11). without further purification for a sensitive and specific
A modification of isotopic dilution principle »is de- determination of Ado-3':5'-P. Dextran T 70 bovine
veloped by BROOKER and coworkers (12) for Ado- serum albumin-coated charcoal is used to accomplish a
3': 5'-P determination. convenient and time-saving separation of the free from
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the bound Ado-3': 5'-P without reducing the sensitivity
of the method.
Thus our assay, compared with the methods 1. c. (13—15)
is easy, rapid, and yet sensitive.
Material and Methods
Chemicals
Adenosine 3': S'-monophosphate, Ado-3': 5'-P
Guanosine 3': 5-monophosphate, Guo-3': 5'-P
Cytidine 3': 5'-monophosphate, Cyd-3':5'-P







Phosphodiesterase from bovine heart, Orthophosphoric diester
phosphohydrolase (EC 3.1.4.).
All these substances were obtained from Boehringer/Mannheim
Bovine serum albumine (Fa. Hoechst).
Binding protein preparation
The Ado-3':5'-P binding protein was obtained from bull adrenal
glands. The adrenal glands were removed immediately after
slaughtering and placed on ice. The fresh adrenal glands were
chopped and homogenized in two volumes of ice-cold buffer I.
The homogenate was centrifuged at 3000 £ for 10 min, followed
by a 6000 £ centrifugation of the supernatant for 15min. Then
the supernatant was removed and aliquots of 2 or 3 ml were
placed in polyethylene bottles, shock-frozen in a cold-mixture
(e. g. methanol-solid CO2 bath), and stored at —20°. Before use a
bottle is thawed and centrifuged at 30,000 £ for 15min. The
supernatant is normally used in a dilution of 1:5 with buffer II
for assay.
No loss of binding-protein activity has been observed after
9 months.
Protein determination
Protein concentration was determined by the method of LOWRY
and coworkers (21) with bovine serum albumin as standard.
Buffers
Buffer I
50mmol/l Tris, 0.25 mol/1 Sucrose, 25 mmol/1 KC1, 5 mmol/1
MgCi2, pH-value was adjusted to 7.4 using HC1.
Buffer I I
50 mmol/1 Tris, 8 mmol/1 theophylline, 6 mmol/1 2-mercapto-
cthanol, pH-valuc was adjusted to 7,4 using HC1
Buff er III
50 mmol/1 Tris, 8 mmol/1 theophylline, 6 mmol 2-mercapto-
ethanol, 0.25% bovine scrum albumine, pH-value was adjusted
to 7.4 using HC1.
Tracer
3H-Ado-3':5'-P, specific activity 24.1 Ci/mmol (NEN-Chemicals).
The substance was shown to be carrier-free (> 99%) and che-
mically pure (thin-layer chromatography on PEI-cellulose with
the solvent system saturated (NH4)2SO4/1 mol/1 sodium acetate/
isopropanol (80:18:2, v/v)).
The saturating concentration for assay was 40 nCi (88,800 dpm)
Sc in t i l l a t ion m i x t u r e
PPO 5.0 g, POPOP 200 mg, naphthalin 100 g in l l dioxan.
Separation mix tu re
5.0 g charcoal (Norit A, Scrva)
0.5 g Dextran T 70 (Pharmacia, Sweden)
50.0 ml Tris-buffer III.
Tissue preparation
Tissue samples (liver, kidney) from ether anesthetized Wistar
rats were frozen in liquid N2 immediately after removing.
Then pieces were weighed (about 10 mg) and homogenized in
1 ml 6% trichloroacetic acid. After centrifugation the supernatant
was extracted 8 times with 5 ml water saturated diethylether.
An aliquot of the aqueous phase was dried and redissolved in
50,ul buffer II for determination of Ado-3':5'-P (see Tab. 1).
Recovery of added 3I I-Ado-3': 5'-P showed that extraction proce-
dure is free from losses (94—108%).
Procedure (Tab. 1).
Results
The competitive binding protein assay of Ado-3' :5'-P
results in a nonlinear dose response curve, when the
bound over free (B/F) ratio or the percent-binding
/ B — N \
ί Υ = 100 · I of labeled compound are plotted
versus dose (Fig. 1).
1—2 total activity;
Tab. 1
Steps in procedure for measurement of Ado-3':5'-P
3—4 control value; 5—20 standard values 21—22 control value of unknown sample; 23 ff. unknown samples




Unknown sample (μΐ) Ο
•H-Ado-3':5'-P(/*l)
(40 nCi) 50
Tris buffer (//!) 250
Binding protein (μ\) 100
0 0 50 50 50
0 0 0.25 0.625 1.25
0 0 0 0 0
50 50 50 50 50
250 150 100 100 100
0 100 100 100 100
Mix gently. Incubation time 2 hours at 4°
Separation:
Charcoal suspen-
sion (A<1) 0 100 100 100 100 100




































































200 μΐ of the supernatant are counted in 10 ml of scintillation liquid. All samples are precisely counted to 1 % statistics.
Quenching is always the same. The efficiency is 43 d= 1 %
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Standard curve for Ado-3': 5'-P assay. Standard deviation is shown
in the curve for p ^ 0.05
Calculation: We use the response variables suggested by ODELL and
coworkers (22)
B = number of counts per minute (c. p. m.) bound in the presence
of standard or unknown unlabeled Ado-3':5'-P
BO = number of c. p. m. bound in the absence of uniabeled Ado-3':5-P
T = the total number of c. p. m. (bound and free)
N = blank: treated as value of nonspecific binding. It is subtracted
from values of B, B0, and T
For more routine dose interpolation the linearisation
according to the method "logit plot" suggested by
RODBARD and coworkers (23) can be used (Fig. 2).
Another method for linearisation is the "single recipro-
cal plot" suggested by us. This model has provided a
satisfactory fit for a wide range of the dose response
curve, when the binding protein is near saturation.
This method is exact, provided that one is dealing with
an univalent homogenous reaction between Ado-3':5'-P
and the binding protein.
Our plot has the advantage of easy and simple curve
calculation. In addition, the plot yields the affinity
constant and the binding capacity of the binding
protein from the ordinate-intercept and the slope of
the curve, if the constant amount of 3H-Ado-3': 5'-P
is known (Fig. 3).
Analysis of data
Precision
In Figure 1 the 95% confidence limits were calculated
assuming normal distribution of the 10 values. The
range of the dose is shown on the abscissa.
The intraassay coefficient of variation averaged 2.6%
(p ^ 0.05). The interassay coefficient of variation
obtained from more than 90 duplicate samples of
Ado-3' :5'-P averaged 6% (p g 0.05) over the range
of measurement.
0.25 0.625 1 1.25 2.5 5 7,5 1012.5
Iogl0 Ado-W-Ptpmol/tubei—*-
Fig, 2
Standard curve for Ado-3':5'-P assay, logit plot
Ordinate: Υ = 100 · Jf """^T on logit scale (left). Logit Υ = Ioge 1QQ_v.








I I I I J_ J_
w 0.25 0,6251 1.25 2 Z5 3 4 5
Ado-3':5-P [pmol/tubej —»-
Fig. 3
Linearisation of the standard curve by a "single reciprocal plot*'.
Affinity constant calculated from slope and intercept of the ordinate
is Κ - 4.3 · 10β 1/mol
Detection limit
Sensitivity has been usually defined as the smallest
amount of substance being measured that can be
significantly distinguished from zero. Under present
conditions the detection limit is 0.25 pmol per tube.
This value is significantly (ρ <Ξ 0.05) different from the
blank value.
We have included the other aspect of sensitivity, the
resolving power, (the ability of the assay to distin-
guish between slightly different concentrations of
Ado-3':5'-P over the whole range of standard curve),
in the concept of precision.
Specificity
In Figure 4 a dose response curve of Ado-3' :5'-P and
related compounds are shown. The ability to compete
with 3H-Ado-3':5'-P for binding site(s) of protein
kinase was determined.
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Nucleotide [pmol/tube]
Fig. 4
Dose response curve of Ado-3':5'-P and related nucleotides
• Ado-3':5'-P; ο Ino-3':5'-P; ^ Guo^S'r '-P; ^ Cyd-3':5'-P; D Urd-3':5'-P; • ATP
It can be shown that the tested compounds do not
cross-react in our assay at the concentrations which
have been found e. g. for Guo-3': 5'-P (24, 25) in many
tissues.
Accuracy
Accuracy is an important criterion of assay reliability.
It depends on sensitivity, precision, specificity, and the
quality of tissue homogenate. A criterion for accuracy
is given by recovery.
In Figures 5 and 6 the recovery is tested by known
amounts of Ado-3':5'-P added at the time of homo-
genisation. The coefficient of variation was 9.5% (for
recovery).
Since competitors or unspecific inhibitors of Ado-
s':5'-P binding may exist in the tissue extract, the
assay could yield estimates of Ado-3': 5'-P which were
too high. The influence of such compounds can be







Recovered amount (p ^0.05) of Ado-3' :5'-P as a function of Ado-
s' :5'-P added to liver homogenate. The mean value of Ado-3':5-P in
the rat liver was 0.8 pmol/mg wet weight. This value is subtracted
from the total amount of Ado-3':5'-P. The dashed line gives 100%
recovery
After treatment with phosphodiesterase, the samples
show the blank value. It can be concluded that the
tissue extracts do not contain any significant amounts
of competitors or unspecific inhibitors of Ado-3':5'-P
that would affect 3H-Ado-3': 5'-P binding to the specific
protein. The possibility that phosphodiesterase in-
activated competing substances in addition to Ado-
S'iS'-P is not completely excluded.
Discussion
Technically more demanding procedures for pre-
paration of binding protein, e. g. the separation of
adrenal cortex from medulla, are not so useful as one
could believe. There is only a small difference between
cortex and medulla with respect to the specific activity
of binding protein (15). More highly purified protein
(from adrenals (20) or from muscle (14)) and a more
rigorous separation method of free and bound Ado-
3':5'-P do not yield essentially higher sensitivity and






Recovered amount (ρ ^ 0.05) of Ado-3' :5'-P as a function of Ado-
s' :5'-P added to kidney homogenate. The mean value of Ado-3' :5'-P
in the rat kidney was 1.5pmol/mg wet weight. This value is sub-
I from the total amount of Ado-3':5'-P. The dashed line givestracted
100% recovery
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can be enhanced by reducing the tracer concentration
and the reaction volume.
We find a 0.4 ml reaction volume the suitable to work
with. We generally carry out all assays at 4—6°, be-
cause of the higher association constant at low tem-
perature.
Undoubtedly a main problem of Ado-3':5'-P assay
concerns the values of the blanks. This blank (i. e. the
apparent amount of Ado-3':5'-P found in a sample
which does not contain Ado-3': 5'-P) consists of
1. competing nucleotide or other material in the
tissue preparation. Material present in the tissue pre-
paration may either compete for the binding site or
may denaturate a part of the binding protein (tending
to cause overestimation of amount of Ado-3':5'-P
present in the tissue extract)
2. substances present in the extract that influence the
adsorbing activity of the unspecific adsorbent (resulting
in a lower unbound Ado-3':5'-P fraction and finally in
underestimation of the amount of Ado-3': 5'-P).
The first point is treated by the specificity and the
accuracy of the assay. The other point can be compen-
sated by the control value of the assay.
The strong affinit}' and the high specificity of binding
protein for Ado-3': 5'-P are the basis for an convenient
and sensitive competitive protein binding assay. Con-
sidering this we determined the affinity-constant of
3H-Ado-3': 5'-P for the binding protein in a SCATCHARD-
plot (26) (Fig. 7). The ratio of bound to free 3H-Ado-
3':5'-P is plotted against the bound 3H-Ado-3': 5'-P.
The linearity suggests single site binding kinetics. The
intercept on the x-axis equals the molarity of binding
sites and the slope equals the negative value of the
binding constant. The affinity constant determined
from ScATCHARD-plot (Fig. 7) is 1.3-108l/mol (4°).
The molarity of binding sites equals 1.13 · 10~8 mol/1.
The 3H-Ado-3':5'-P affinity was tested under assay
conditions. For separation of bound and free 3H-Ado-
3':5'-P, the adsorbent coated charcoal is added to the
system at equilibrium for a very short time only, in
order to prevent the dissociation of the protein-3H-
Ado-3':5'-P complex. The equilibrium-state has to be
maintained. The charcoal concentration used is rel-
atively high, compared with the literature values (27).
Smaller charcoal concentrations produced unsatis-
factory preparation results. The maintenance of strictly
controlled conditions (stirring, temperature, duration
of contact) is necessary for reproducibility. The
equilibrium study with binding protein and 3H-Ado-
3':5'-P has shown that the free energy of binding has
the relatively high value of 10 kcal/mol. The free
energy change can be calculated by the formula
AG° = — RT In K (R = gas-constant, T = abs. tem-
perature, K = affinity constant). It is composed of a
very high negative enthalpy change in association with
a negative change of entropy. The thermo dynamic
data are interpreted as indicative of very tight fit of the
interacting components so that the enthalpy is drastically
1 2 3 4 5 6 7
Binmol / l ] ·
8 9 10 11 12
Fig. 7
SCATCHARD-plot.
Ratio B/F is plotted versus B
Affinity constant calculated from slope is K = 1.3- 10el/mol. The
molarity of binding sites calculated from the intercept of abscissa is
1.1 · 10-8mol/l
reduced and the total order of the system is much
increased resulting in a negative entropy change.
The binding protein is relatively specific for Ado-
3':5'-P. Unlabeled Ado-3':5'-P competes with the
labeled form for binding sites. It can be assumed that
labeled and unlabeled Ado-3' :5'JP have the same
affinity to the binding protein.
Other nucleotides do not compete effectively, as shown
in Figure 4 and Table 2, except the 1 Of old quantities of
Ino-3': 5'-P and lOOfold quantities of Guo-3': 5'-P which
displace labeled Ado-3': 5'-P from the binding protein by
50%. The competition by Ino-3':5'-P and, to a lesser
extent, by Guo-3': 5'-P, and the total lack of competition
of ATP, ADP, Ado-S'-P and Ado-3'-P, indicate that the
3':5'-ring is responsible for specificity of the binding
to the protein, but not the adenine part of the adenine
nucleotides.
A very interesting fact is the great difference between
the binding of N6-mono- and N6-2'O-dibutyryl deri-
vatives of Ado-3':5'-P to the protein kinase. The
Tab. 2
Relative binding of various nucleotides to Ado-3':5'-P binding
protein. The ability of Ado-3':5'-P to inhibit 3H-Ado-3' :5'-P binding
was arbitrarily set at 100%. Relative binding affinity of any given
(Ado-3':5'-P)
compound is calculated as —; -r— · 100 for 50% inhibition of(compound)
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Schütte! m ischer
mit exzentrischen Lagern
[Multi-Axle Rotator) von Deiiley
greiner
Durch dieses neuartige System erhalten die eingelegten
Röhrchen über die exzentrische Aufhängung der fünf
parallel zueinander laufenden Wellen nicht nur die übliche
Drehung, sondern gleichzeitig auch eine schaukelnde Be-
wegung. Die Wellen liegen zwar stets parallel zueinander,
sind jedoch um 180° phasenverschoben gegeneinander
angetrieben, so daß die Röhrchen während des Misch-
Vorganges neben der ständigen Drehung Schaukel- und
Kippbewegungen in einem Winkel von circa 10° unter-
worfen sind.
Die Röhrchen bewegen sich frei auf den Wellen und
können beliebig — ohne den Mischer anzuhalten — auf-
gelegt oder abgehoben werden.
Disk-
EfektropDiorese
analytische Trennkammer E A 90
mit komplettem oder beliebigem Zubehör
präparative Trennkammer E A100
mit synchroner Automatik bis zum Fraktionsteiler
Densitometer PHI 3 und PH1 5
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Abb. 4: Bleiaufnahme und -ausscheidung
Therapie der
Vergiftungen
Von Prof. Dr. S. MOESCHLIN, Solothurn
5., überarbeitete und erweiterte Auflage
1972. XII, 533 Seiten, 110 Abbildungen, 10 Tabellen
Format 17,5 X 26 cm, Ganzleinen DM 79,-
ISBN3133784056
Aus einer Besprechung der 4. Auflage:
Die 4., neubearbeitete und erweiterte Auflage des Moeschlin gibt Anlaß, dieses ausgezeichnete Buch, das nahezu
sämtliche möglichen Vergiftungen aus klinischer Sicht behandelt, in Erinnerung zu bringen: Ein modernes Stan-
dardwerk der klinischen Toxikologie und Gewerbemedizin, das für jeden Arzt und Apotheker unentbehrlich ist ~
oder doch sein sollte, wenn man an die unübersehbar große Zahl der in der Praxis möglichen Vergiftungsgfälle
denkt.
Neben den anorganischen Stoffen und organischen Verbindungen, nahezu sämtlichen Arzneimittelklassen und
einer großen Zahl von Handelsprodukten, Kampfstoffen und Insektiziden werden auch Tier- und-Pflanzengifte
und Nahrungsmittelvergiftungen behandelt. Immer wird man sich der großen persönlichen Erfahrung des Autors
bewußt, ohne die dieses Werk in seiner Praxisnähe nicht denkbar wäre. — Moeschlin macht unter Anführung
zahlreicher Beispiele deutlich, daß eigentlich jeder Stoff giftig ist — es ist nur eine frage der Konzentration. Und
gerade deshalb ist das Buch auch für den Chemiker interessant, der sich nur allzu oft nicht bewußt ist, wie gefähr-
lich die Stoffe sind, mit denen er — oder seine Laboranten — umgehen, und welches im Fall einer Vergiftung die
richtigen Sofortmaßnahmen sind. M. Reinhardt, Chemiker Zeitung, Chemische Apparatur
(94)





Dose response curve of Ado-3':5'-P and its butyryl derivatives
Q Ado-3':5'-P; D NMnonobutyryl Ado-3':5'-P derivative O N«-2'O-dibutyryl Ado-3':5'-P derivative
N6-monobutyryl derivative competes very effectively
with 3H-Ado-3':5'-P, but the dibutyryl derivative
requires a 400fold higher concentration for 50% in-
hibition (see Fig. 8).
It can be suggested, that the Ado-3':5'-P derivative
monobutyrylated in position 2Ό is not so effective
for protein kinase activity as the derivative mono-
butyrylated in position N6, e. g. the finding by HENION
and coworkers (28) that the N6-derivatives in the liver
phosphorylase system retained some activity, but those
substituted at the 2'O-position were inactive, could be
interpreted in this way.
The "single reciprocal plot" presented in Figure 3 is
a new method for linearisation of the dose response
curve. This linearisation has the advantage that it is
exact provided that one is dealing with the single site
binding kinetics. In the ScATCHARD-plot (Fig. 7) and
the "single reciprocal plot" (Fig. 3) the data yield a
straight line, if dose response is limited to the given
range, in which Ado-3':5'-P is determined. Con-
sidering the linearity in both plots, it is reasonable to
assume a single site binding kinetic.
A binding system which obeys the law of mass action
and in which the binding sites are assumed to be
independent can be treated similarly to the equilibrium
treatment of enzyme action. Where such equilibrium
treatment is appropriate, the classical graphical methods
are often used, e. g. the double reciprocal plot (first
represented by LINEWEAVER and BURK (29) in enzyme
kinetics) and the ScATCHARD-plot. The "single recip-
rocal plot" proposed by us (also used in enzyme in-
hibition studies) provides that the labeled and unlabeled
compounds possess affinity for the binding protein and
are able to displace one another from the binding site
of the protein. In other words the protein can form a
complex PL* with the kbeled compound (L*) and a
complex PL with the unlabeled compound (L), but can
not form a complex in which both L* and L are attached
to the binding protein. This is comparable to the
equilibrium treatment of competitive inhibition of an
enzyme reaction.
The scheme applicable to a competitive reaction is as
follows :
PL
Ρ == binding protein
L = ligand unlabeled
L* = ligand labeled
PL* = binding protein labeled ligand complex (can be
measured)
PL = binding protein ligand complex
Κ = v~~ = dissociation constant of the PL*-complexk+i r
k-iKj = - — = dissociation constant of the PL-complex.k+i r
In order to derive the rate equation at equilibrium, the
following three simultaneous algebraic equations (eq.
1 — 3) must be solved in terms of the measurable
variables ([L*], [L], and total protein ([P]0)) and equi-
librium constants
-^pi - Ο - k+1 [P] [L*] - fc_, [PL·]
W-O-WM- [PL]








This equation (eq. 4) can be transformed in
[PL*] — [P]0 V* ' [L*] / ^ K, IPJo [L*] W (eq< 5^
If the same compound is given in labeled and un-
labeled form, it can be assumed that K = Kj. Conse-
quently the eq. 5 is simplified to
1 1
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Under the conditions given, a straight line results if
the data of the saturation analysis are plotted according
to equation (eq. 6). The variable PL* is measured
after separation of free and bound labeled compound,
PL* being equivalent to the bound part (B) of the
labeled compound. The other variable L is varied by
known concentrations of unlabeled compound. Since
the labeled compound concentration is known (from
specific activity), the concentration of the binding
sites (P0) and the affinity constant (1/K) are available
from slope and the intercept of the straight line in the
"single reciprocal plot".
The dose interpolation is readily done with the use of
equation 6. The "single reciprocal plot" provides a
satisfactory fit for a considerable portion of a dose-
response curve. The chief virtues of this method are the
ease and the simplicity with which the calculation may be
done on a hand calculator and with which the estimation
of the parameters K and P0 is possible. A computer
program for fitting the curve with the use of least-
squares regression analysis is very easy, too. Moreover,
this method allows the estimation of the affinity constant
(—1 of any competitors of a labeled ligand, if its
concentration is varied. Upon extrapolation the re-
sulting straight lines intersect at one point with the
coordinates (— K-J -^j.
Finally, it should be mentioned 't?hat over an unusually
wide dose range the linearisation in the "single re-
ciprocal plot" is not satisfactory. The "single reciprocal
plot" provides an optimal fit for low and medium dose
region of the curve but not for high dose region.
Considering that we have derived equation 6 on con-
dition that a univalent homogeneous reaction occurs,
but may be there two distinct orders of protein binding
sites each with its own characteristic binding constant.
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